Welcome to Our Parkinson's Place

I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible. I have Parkinson's
diseases as well and thought it would be nice to have a place where
updated news is in one place. That is why I began this blog.
I am not responsible for it's contents, I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish. This is for you to read and to always keep an open mind.
Please discuss this with your doctor, should you have any questions, or concerns. Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. Please No advertisers, and No Information about Herbal treatments. Please no advertisements.
This is a free site for all.
Thank you.

Thursday, April 6, 2017

Investigators from Neurodon LLC Zero in on Parkinson's Disease (A new target for Parkinson's disease: Small molecule SERCA activator CDN1163...

April 6, 2017

Investigators from Neurodon LLC Zero in on Parkinson's Disease (A new target for Parkinson's disease: Small molecule SERCA activator CDN1163ameliorates dyskinesia in 6-OHDA-lesioned rats)

By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- New research on Parkinson's disease is the subject of a report. According to news reporting out of Schererville, Indiana, by NewsRx editors, the research stated, "Endoplasmic reticulum (ER) stress is intimately linked to Parkinson's disease (PD) pathophysiology. Disrupted intracellular calcium homeostasis is a major cause of the ER stress seen in dopaminergic neurons, leading to the cell death and subsequent loss of movement and coordination in patients."

Our news journalists obtained a quote from the research from Neurodon LLC, "Dysfunctional calcium handling proteins play a major role in the promulgation of ER stress in PD. Specifically, compromised sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) has been identified as a major cause of ER stress and neuron loss in PD. We have identified a small molecule activator of SERCA that increases ER calcium content, rescues neurons from ER stress-induced cell death in vitro, and shows significant efficacy in the rat 6-hydroxydopamine (6-OHDA) model of PD."

According to the news editors, the research concluded: "Together, these results support targeting SERCA activation as a viable strategy to develop disease-modifying therapeutics for PD."

For more information on this research see: A new target for Parkinson's disease: Small molecule SERCA activator CDN1163 ameliorates dyskinesia in 6-OHDA-lesioned rats. Bioorganic & Medicinal Chemistry, 2017;25(1):53-57. Bioorganic & Medicinal Chemistry can be contacted at: Pergamon-Elsevier Science Ltd, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, England. (Elsevier -; Bioorganic & Medicinal Chemistry -

Our news journalists report that additional information may be obtained by contacting R. DahlNeurodon LLCSchererville, IN 46375, United States(see also Parkinson's Disease).

Keywords for this news article include: Schererville, IndianaUnited States, North and Central America, Central Nervous System Diseases and Conditions, Neurodegenerative Diseases and Conditions, Musculoskeletal Diseases and Conditions, Basal Ganglia Diseases and Conditions, Brain Diseases and Conditions, Neurologic Manifestations, Parkinsonian Disorders, Parkinson's Disease, Movement Disorders, Dyskinesias, Neurodon LLC.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC

No comments:

Post a Comment